ReviewComprehensive review on tumour active palladium compounds and structure–activity relationships

Add time:08/22/2019    Source:sciencedirect.com

This article provides a comprehensive review of palladium compounds that have been evaluated for anticancer activity in vivo or in vitro from the era of discovery of cisplatin up to 2015. In total, 847 compounds have been discussed into three categories namely (1) potent palladium compounds, (2) palladium compounds with comparable activity and (3) palladium compounds with insignificant activity. Structure activity relationships are proposed that may aid in the design of new palladium compounds with greater antitumour activity.

We also recommend Trading Suppliers and Manufacturers of cis-Dimethyl(N,N,N',N'-tetramethylethylenediamine)palladium(II), 99% (cas 113822-11-0). Pls Click Website Link as below: cas 113822-11-0 suppliers

Prev:Pancreastatin, a Regulatory Peptide Derived From Chromogranin A☆
Next:Review articlePlatinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives)